Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of three CSL412 influenza vaccine formulations in adults and older adults
2007-000272-16Phase 2Completed
- Sponsor
- CSL Limited
- Start
- Mar 2007
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CSL412 and omeprazole in influenza (4 arms), sponsored by CSL Limited. Primary endpoints: Immunogenicity against influenza haemagglutinin antigens and Safety and tolerability. Started Mar 2007; status: completed.
02
Drugs
CSL412omeprazole
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-000272-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000272-16.